Cardiac complications of cancer treatment

Anesthesiology Clinics of North America

Volumn 16, Issue 3, 1998, Pages 597-604

  Swafford, J ^a   Gibbs, H R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; BIOLOGICAL RESPONSE MODIFIER; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; INTERFERON; INTERLEUKIN 2; PACLITAXEL; VINCA ALKALOID;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HODGKIN DISEASE; HUMAN; PATIENT CARE; REVIEW; ST SEGMENT;

EID: 0031695485     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8537(05)70045-6     Document Type: Article

References (32)

1. J. Alexander N. Dainiak H. Berger Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiography N Engl J Med 300 1979 278
2. M. Ali M. Ewer H. Gibbs Late doxorubicin-associated cardiotoxicity in children: The possible role of intercurrent viral infection Cancer 74 1994 182
3. M.M. Applefeld R.G. Slawson K.M. Spicer Long-term cardiovascular evaluation of patients with Hodgkin's disease treated by thoracic mantle radiation therapy Cancer Treat Rep 66 1982 1003
4. S. Arbuck H. Strauss E. Rowinsky A reassessment of cardiac toxicity associated with Taxol Monogr Natl Cancer Inst 15 1993 117
5. M. Billingham J. Mason M. Bristow Anthracycline cardiomyopathy monitored by morphologic changes Cancer Treat Rep 62 1978 865
6. C.D. Buckner R.H. Rudolph A. Fefer High dose cyclophosphamide therapy for malignant disease Cancer 29 1972 357
7. J. Eskilsson M. Albertsson Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil Acta Oncol 29 1990 1001
8. M. Ewer C. Carrasco B. MacKay Cardiac biopsy procedures at a cancer center Proc Am Soc Clin Oncol 10 1991 336
9. G. Fonseca V. Valero A. Buzdar Decreased cardiac toxicity by TLC D-99 (liposomal doxorubicin) in the treatment of metastatic breast carcinoma Proc Am Soc Clin Oncol 14 1995 99
10. J. Gottdiener F. Appelbaum V. Ferrans Cardiotoxicity associated with high dose cyclophosphamide therapy Arch Intern Med 141 1981 758
11. J.S. Gottdiener M.J. Katin J.S. Boner Late cardiac effects of therapeutic mediastinal irradiation N Engl J Med 308 1983 569
12. R. Labianca G. Beretta M. Clerici Cardiac toxicity of 5-fluorouracil: A study on 1083 patients Tumori 68 1982 505
13. R. Lee M. Lotze J. Skibber Cardiorespiratory effects of immunotherapy with interleukin-2 J Clin Oncol 7 1989 7
14. S. Legha R. Benjamin B. Mackay Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion Ann Intern Med 96 1982 133
15. B. Mackay M. Ewer C. Carrasco Assessment of anthracycline cardiomyopathy by endomyocardial biopsy Ultrastruct Pathol 18 1994 203
16. R.G. Martin J.D. Ruckdeschel P. Chang Radiation-related pericarditis Am J Cardiol 35 1975 216
17. R.A. McReynolds G.L. Gold W.C. Roberts Coronary heart disease after mediastinal irradiation for Hodgkin's Am J Med 60 1976 39
18. P. Ravdin V. Valero Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancer Semin Oncol 22 1995 17
19. S. Reykdal R. Sham P. Kouides Cytarabine-induced pericarditis: A case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy Leuk Res 19 1995 141
20. S. Rezkalla R. Kloner J. Ensley Continuous ambulatory ECG monitoring during fluorouracil therapy: A prospective study J Clin Oncol 7 1989 509
21. E. Rowinsky W. McGuire T. Guarnieri Cardiac disturbances during the administration of Taxol J Clin Oncol 9 1991 1704
22. W. Samlowski J. Ward C. Craven Severe myocarditis following high-dose interleukin-2 administration Arch Pathol Lab Med 113 1989 838
23. M. Sonnenblick A. Rosin Cardiotoxicity of interferon Chest 99 1991 557
24. J. Speyer M. Green E. Kramer Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer N Engl J Med 319 1988 745
25. L.J. Steinherz P.G. Steinherz Cardiac toxicity 4 to 20 years after completing anthracycline therapy JAMA 266 1672
26. L.J. Steinherz P.G. Steinherz Cyclophosphamide cardiotoxicity Cancer Bull 37 1985 231
27. J.R. Stewart L.F. Fajurdo Radiation-induced heart disease Radiol Clin North Am 9 1971 511
28. P. Vaitkus D. Grossman K. Fox Complete heart block due to interleukin-2 therapy Am Heart J 119 1990 978
29. A. van Oosterom D. Schrivers docetaxel (Taxotere), a review of preclinical and clinical experience. Part II, clinical experience Anticancer Drugs 6 1995 356
30. F. Villani A. Guindani A. Pagnoni 5-Fluorouracil cardiotoxicity Tumori 65 1979 487
31. D. Von Hoff M. Layard P. Basa Risk factors for doxorubicin-induced congestive heart failure Ann Intern Med 91 1979 710
32. R. Weiss R. Donehower P. Wiernik Hypersensitivity reactions from Taxol J Clin Oncol 8 1990 1263